Discover Lead Molecules Against Difficult Membrane Targets Inaccessible by Hybridoma Methods

All Resources

App Note

Learn about how the Opto™ Plasma B Discovery workflow increases hit recovery for difficult membrane-bound targets and provides access to greater sequence diversity when compared to traditional hybridoma methods.

First Name*

Last Name*

Email*

Company Name*

Country*

Application Area*

Research Area*

By submitting this form, I confirm that I would like to receive information from Bruker Cellular Analysis and I agree to the Website Privacy Policy and Terms of Conditions.*

What's Inside

In this App Note we discuss:

Discover up to 10-fold more hits against soluble and cell membrane antigens in days not weeks.

Generate diverse lead panels by sampling >50-fold greater sequence diversity.

Increase campaign yield and efficiency to reduce costs by 20-fold.

A Deeper Look

More about this App Note

Discover Lead Molecules Against Difficult Membrane Targets

In this application note, we demonstrate how the Opto Plasma B Discovery workflow increases hit recovery for a difficult membrane-bound target and provides access to more than 50-fold greater sequence diversity than a hybridoma workflow. Download to learn more and review the case studies.

Get the App Note

Back to the Top